Table 1 Demographic data of thalassemia patients.
Patient characteristics | n = 131 |
|---|---|
Gender, n (%) | |
Male | 43 (32.8) |
Female | 88 (67.2) |
Age (year) | 35 ± 11 |
Education, n (%) | |
Primary education | 23 (17.5) |
Junior high school | 11 (8.4) |
Senior high school | 36 (27.5) |
Bachelor’s degree | 58 (44.3) |
Master’s degree | 3 (2.3) |
Thalassemia typing, n(%) | |
Hemoglobin H | 22 (16.8) |
Beta thalassemia/hemoglobin E | 82 (62.6) |
Homozygous beta-thalassemia | 27 (20.6) |
Splenectomy, n(%) | |
Yes | 64 (48.9) |
No | 67 (51.1) |
Transfusion dependent, n(%) | |
Yes | 79 (60.3) |
No | 52 (39.7) |
Hemoglobin (g/dl) | 7.2 ± 1.3 |
Hematocrit (%) | 23.2 ± 4.9 |
Serum ferritin (ng/ml) | 1324 (1497) |
Maximum level of serum ferritin in the past 5 years (ng/ml) | 1959 (2221) |
Iron chelating agents, n(%) | |
Deferoxamine | 8 (6.1) |
Deferiprone | 48 (36.6) |
Deferasirox | 11 (8.4) |
Deferoxamine + deferiprone | 21 (16.0) |
Deferoxamine + deferasirox | 12 (9.2) |
No | 31 (23.7) |
